Cas:131117-90-3 4-(2-methoxybenzoyl)benzonitrile manufacturer & supplier

We serve Chemical Name:4-(2-methoxybenzoyl)benzonitrile CAS:131117-90-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-(2-methoxybenzoyl)benzonitrile

Chemical Name:4-(2-methoxybenzoyl)benzonitrile
CAS.NO:131117-90-3
Synonyms:4-cyanophenyl(2-methoxyphenyl)methanone;4-CYANO-2′-METHOXYBENZOPHENONE
Molecular Formula:C15H11NO2
Molecular Weight:237.25300
HS Code:2926909090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:444.8ºC at 760 mmHg
Density:1.21g/cm3
Index of Refraction:1.601
PSA:50.09000
Exact Mass:237.07900
LogP:2.79788

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-cyanophenyl(2-methoxyphenyl)methanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-CYANO-2′-METHOXYBENZOPHENONE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-CYANO-2′-METHOXYBENZOPHENONE Use and application,4-cyanophenyl(2-methoxyphenyl)methanone technical grade,usp/ep/jp grade.


Related News: Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector. 4-(2-methoxybenzoyl)benzonitrile manufacturer Production of J&J’s vaccine at the Baltimore site was halted by U.S. authorities in April and J&J was put in charge of manufacturing at the plant. 4-(2-methoxybenzoyl)benzonitrile supplier Production of J&J’s vaccine at the Baltimore site was halted by U.S. authorities in April and J&J was put in charge of manufacturing at the plant. 4-(2-methoxybenzoyl)benzonitrile vendor Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 4-(2-methoxybenzoyl)benzonitrile factory Taking Teva as an example, it has 2 large R & D centers and 3 professional R & D centers in 5 countries, which effectively supports the development of Teva’s generic pharmaceutical sector.